Intramol (Timolol maleate) is a beta1 and beta2 (non-selective) adrenergic receptor-blocking agent, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma.

It is used in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The dose is one drop of Timolol in the affected eye(s) once daily. Because in some patients the intraocular pressure-lowering response to Timolol may require a few weeks to stabilize, evaluation should include a determination of intraocular pressure after approximately 4 weeks of treatment.

Timolol has little or no effect on the pupil and should not be used alone in the treatment of angle-closure glaucoma.
Patients should not usually receive two topical ophthalmic beta-adrenergic blocking agents concurrently. Every dropper bottle contains 5 ml of sterile solution. Each ml contains Timolol Maleate BP equivalent to Timolol 5.0 mg.